会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明申请
    • MYOGLOBIN AS EARLY PREDICTOR OF MYOCARDIAL INFARCTION
    • MYOGLOBIN作为心肌梗塞早期预后因素
    • US20100285595A1
    • 2010-11-11
    • US12720063
    • 2010-03-09
    • Georg HessHendrik HuedigRosemarie Kientsch-EngelDietmar Zdunek
    • Georg HessHendrik HuedigRosemarie Kientsch-EngelDietmar Zdunek
    • G01N33/72
    • G01N33/6887G01N2333/805G01N2800/324
    • The present invention relates to a method for diagnosing myocardial infarction in a subject who suffers from acute coronary syndrome and has a cardiac troponin level, which is detectable, but lower than the level that is considered as being indicative for a myocardial infarction. Moreover, the present invention relates to a method for identifying a subject being susceptible to cardiac intervention, wherein the subject suffers from acute coronary syndrome and has a cardiac troponin level which is detectable, but lower than a level that is considered as being indicative for a myocardial infarction. The methods of the present invention are based on the determination of myoglobin and, optionally, Heart-type fatty acid binding protein (H-FABP) in a sample of said subject and comparing the amount of myoglobin and, optionally, H-FABP to reference amounts. Also comprised by the present invention are kits or devices to carry out the methods of the present invention.
    • 本发明涉及一种用于诊断患有急性冠状动脉综合征且具有心肌肌钙蛋白水平的受试者心肌梗塞的方法,其可检测但低于被认为是指示心肌梗塞的水平。 此外,本发明涉及用于识别易受心脏干预的受试者的方法,其中所述受试者患有急性冠状动脉综合征,并且具有可检测但是低于被认为是指示性的水平的心脏肌钙蛋白水平 心肌梗死 本发明的方法是基于在所述受试者的样品中测定肌红蛋白和任选的心脏型脂肪酸结合蛋白(H-FABP),并将肌红蛋白和任选的H-FABP的量与参考 金额 本发明还包括用于实施本发明方法的试剂盒或装置。